Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 174,960 | 90,636 | 74,679 | 60,574 | 127,106 |
| Marketable Securities | 657,371 | 745,923 | 821,365 | 876,295 | 907,405 |
| TOTAL | $864,436 | $868,839 | $928,383 | $973,575 | $1,064,137 |
| Non-Current Assets | |||||
| PPE Net | 55,236 | 50,822 | 48,077 | 46,863 | 45,589 |
| Investments And Advances | 359,373 | 445,463 | 450,994 | 490,723 | 0 |
| Other Non-Current Assets | 95,135 | 88,889 | 75,111 | 69,930 | 44,191 |
| TOTAL | $509,744 | $585,174 | $574,182 | $607,516 | $89,780 |
| Total Assets | $1,374,180 | $1,454,013 | $1,502,565 | $1,581,091 | $1,153,917 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,137 | 9,594 | 13,936 | 11,855 | 9,483 |
| Accrued Expenses | 91,071 | 38,320 | 33,039 | 42,662 | 68,499 |
| Other current liabilities | N/A | 31,143 | 19,787 | 20,553 | N/A |
| TOTAL | $102,208 | $87,093 | $74,533 | $82,582 | $77,982 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 36,673 | 42,794 | 40,981 | 43,034 | 44,981 |
| TOTAL | $42,288 | $48,425 | $40,981 | $43,034 | $44,981 |
| Total Liabilities | $144,496 | $135,518 | $115,514 | $125,616 | $122,963 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 145,215 | 143,922 | 143,165 | 142,609 | 139,160 |
| Common Shares | 1,768 | 1,764 | 1,757 | 1,751 | 1,711 |
| Retained earnings | -1,538,984 | -1,424,231 | -1,317,039 | -1,218,013 | -1,116,211 |
| Other shareholders' equity | 2,020 | 5,529 | -2,659 | -1,296 | 643 |
| TOTAL | $1,229,684 | $1,318,495 | $1,387,051 | $1,455,475 | $1,030,954 |
| Total Liabilities And Equity | $1,374,180 | $1,454,013 | $1,502,565 | $1,581,091 | $1,153,917 |